Veterinary Biomarkers Market to Grow with a CAGR of 12.30% through 2030

Rising Prevalence of Animal Diseases and Zoonotic Infections and Growing Companion Animal Population and Humanization of Pets are expected to drive the Global Veterinary Biomarkers Market growth in the forecast period, 2026-2030

According to TechSci Research report, “Veterinary Biomarkers Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2030F”, the Global Veterinary Biomarkers Market stood at USD 965.53 Million in 2024 and is anticipated to grow with a CAGR of 12.30% in the forecast period, 2026-2030.

The rising global demand for animal-derived food products, including meat, dairy, and eggs, has placed livestock health management at the forefront of industry priorities. Veterinary biomarkers have emerged as critical tools in monitoring herd health, enabling early disease diagnosis, and enhancing overall productivity. As governments and industry stakeholders intensify efforts to control livestock diseases and improve food security, the demand for biomarker-based diagnostics continues to grow, further driving market expansion.

Technological advancements in veterinary diagnostics and biotechnology are reshaping the market landscape. Innovations in point-of-care (POC) testing, next-generation sequencing (NGS), and multiplex assays have significantly improved biomarker-based diagnostic accuracy and accessibility for veterinarians. Moreover, the integration of artificial intelligence (AI) and machine learning (ML) into diagnostic platforms is revolutionizing predictive analytics and precision diagnostics, leading to more efficient disease management and treatment planning.

The market is also benefiting from rising investments in veterinary research and development (R&D) by pharmaceutical companies, diagnostic firms, and government agencies. These investments are accelerating the discovery of novel biomarkers, enhancing the commercial viability of biomarker-based diagnostic tools, and expanding their applications in veterinary medicine. Public and private funding initiatives focused on animal healthcare innovation are further fueling the commercialization and adoption of advanced biomarker technologies.

Regulatory bodies worldwide are fostering market growth by implementing supportive policies and streamlined approval processes for veterinary diagnostics. Agencies such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the World Organisation for Animal Health (OIE) are actively working to facilitate the approval and market entry of biomarker-driven diagnostic products, ensuring faster accessibility for veterinarians and animal health professionals.

The shift toward personalized veterinary medicine is another key driver shaping the market. Biomarkers are playing a crucial role in tailoring treatment plans based on individual genetic and physiological profiles, particularly in veterinary oncology, where targeted biomarker-driven therapies are gaining traction. As the demand for precision medicine in animal healthcare grows, biomarker-based diagnostics are expected to become even more integral to clinical decision-making and treatment optimization.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Veterinary Biomarkers Market”

The Global Veterinary Biomarkers Market is segmented into animal type, product type, application, disease type, regional distribution, and company.

Based on its application, The disease diagnostics segment holds a dominant position in the global veterinary biomarkers market, driven by the increasing need for early and accurate disease detection in animals. Veterinary biomarkers play a crucial role in diagnosing a wide range of infectious, inflammatory, metabolic, and neoplastic diseases, enabling veterinarians to implement timely interventions and improve treatment outcomes. As animal health concerns grow—both in companion animals and livestock—the demand for biomarker-based diagnostics continues to rise, making this segment the largest contributor to market growth. The prevalence of zoonotic diseases, chronic illnesses, and emerging infectious diseases has intensified the need for reliable veterinary diagnostics. Conditions such as canine cancer, feline leukemia, bovine respiratory disease, and equine metabolic syndrome require precise and efficient diagnostic tools, which biomarkers provide. Unlike conventional diagnostic methods, biomarker-based tests allow for early disease identification, reducing treatment costs, minimizing animal suffering, and improving survival rates. This growing emphasis on preventive veterinary care is a major factor driving the dominance of the disease diagnostics segment.

Innovations in molecular diagnostics, immunoassays, and point-of-care (POC) testing have significantly improved the efficacy and accessibility of biomarker-based disease diagnostics. Technologies such as next-generation sequencing (NGS), enzyme-linked immunosorbent assays (ELISA), and polymerase chain reaction (PCR) testing have enhanced accuracy and speed, enabling veterinarians to make data-driven clinical decisions. Furthermore, the integration of artificial intelligence (AI) and machine learning (ML) into diagnostic platforms is revolutionizing the predictive capabilities of biomarker-based tests, allowing for real-time disease monitoring and risk assessment.

Based on region, Asia Pacific is poised to witness fastest market growth in the Global Veterinary Biomarkers Market. The Asia Pacific pet care industry has experienced unprecedented growth, fueled by urbanization, increasing disposable income, and shifting consumer preferences toward pet companionship. Countries such as China, India, Japan, and South Korea have witnessed a significant rise in pet ownership, leading to greater spending on pet healthcare services. With pet owners becoming more aware of preventive diagnostics and disease management, the demand for biomarker-based tests for companion animals is rising. The increasing prevalence of chronic conditions like cancer, arthritis, and inflammatory diseases in pets has further boosted the adoption of biomarker-driven diagnostics to enable early disease detection and personalized treatment plans.

The Asia Pacific region is home to some of the world’s largest livestock-producing countries, including China, India, Australia, and Vietnam. The rising demand for animal-derived food products such as meat, dairy, and eggs has put pressure on farmers and agribusinesses to maintain herd health and prevent disease outbreaks. Infectious diseases such as foot-and-mouth disease (FMD), avian influenza, swine fever, and bovine mastitis pose a major threat to livestock productivity, leading to economic losses and trade restrictions. Veterinary biomarkers are increasingly being used for early disease detection, herd monitoring, and precision livestock farming, ensuring better disease control and enhanced productivity in the livestock sector.

Major companies operating in Global Veterinary Biomarkers Market are:

• Zoetis Inc.
• Virbac SA
• Life Diagnostics Inc
• Acuvet Biotech
• Merck & Co., Inc.
• IDEXX Laboratories, Inc.
• Mercodia AB
• Antech Diagnostics Inc

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“The Global Veterinary Biomarkers Market is undergoing a rapid transformation, driven by technological advancements, changing consumer attitudes toward pet care, and a growing emphasis on personalized medicine for animals. These trends are poised to shape the future of veterinary biomarkers, enhancing the health and well-being of animals while advancing the field of veterinary medicine. As these trends continue to evolve, more effective disease management, improved treatment outcomes, and a brighter future for animal healthcare worldwide could be anticipated,” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“Veterinary Biomarkers Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Animal Type (Companion Animals, Production Animals), By Product Type (Biomarkers, Kits & Reagents, Biomarker Readers), By Application (Disease Diagnostics, Preclinical Research, Others), By Disease Type (Inflammatory & Infectious Diseases, Cardiovascular Diseases, Skeletal Muscle Diseases, Tumor, Others), By Region & Competition, 2020-2030F”, has evaluated the future growth potential of Global Veterinary Biomarkers Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Veterinary Biomarkers Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: sales@techsciresearch.com

Website: www.techsciresearch.com